HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
 Help
ORGO [NASD]
Organogenesis Holdings Inc.
Healthcare | Drug Manufacturers - Specialty & Generic | USA
statements
Index- P/E7.66 EPS (ttm)0.64 Insider Own0.90% Shs Outstand128.79M Perf Week-6.69%
Market Cap659.19M Forward P/E11.09 EPS next Y0.44 Insider Trans-58.97% Shs Float63.42M Perf Month-13.01%
Income85.00M PEG3.18 EPS next Q0.08 Inst Own46.00% Short Float11.45% Perf Quarter-36.38%
Sales463.60M P/S1.42 EPS this Y358.80% Inst Trans3.98% Short Ratio6.90 Perf Half Y-46.90%
Book/sh1.89 P/B2.58 EPS next Y35.38% ROA21.20% Target Price14.50 Perf Year-70.64%
Cash/sh0.80 P/C6.11 EPS next 5Y2.41% ROE39.90% 52W Range4.62 - 17.50 Perf YTD-47.19%
Dividend- P/FCF20.73 EPS past 5Y96.00% ROI32.40% 52W High-71.49% Beta1.35
Dividend %- Quick Ratio2.50 Sales past 5Y- Gross Margin75.50% 52W Low8.01% ATR0.29
Employees950 Current Ratio2.80 Sales Q/Q-4.40% Oper. Margin12.80% RSI (14)42.69 Volatility6.09% 5.28%
OptionableYes Debt/Eq0.30 EPS Q/Q-99.10% Profit Margin18.30% Rel Volume0.32 Prev Close4.88
ShortableYes LT Debt/Eq0.29 EarningsMay 10 AMC Payout0.00% Avg Volume1.05M Price4.99
Recom1.00 SMA20-2.76% SMA50-13.62% SMA200-42.25% Volume299,390 Change2.25%
Jan-10-20Initiated SVB Leerink Outperform $9
Aug-26-19Resumed Credit Suisse Outperform $9 → $10
May-02-19Initiated Credit Suisse Outperform $9
Apr-17-19Initiated Oppenheimer Outperform $11
Apr-11-19Initiated SunTrust Buy $11
Jun-30-22 07:30AM  
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2022 Financial Results on August 9, 2022
GlobeNewswire
Jun-10-22 09:25AM  
2 Strong Buy Stocks Trading at Rock-Bottom Prices
TipRanks
Jun-02-22 06:42AM  
Shareholders in Organogenesis Holdings (NASDAQ:ORGO) are in the red if they invested a year ago
Simply Wall St.
May-11-22 05:00AM  
Organogenesis Holdings Inc. (ORGO) Q1 2022 Earnings Call Transcript
Motley Fool +6.33%
May-10-22 05:35PM  
Organogenesis (ORGO) Q1 Earnings Lag Estimates
Zacks
04:05PM  
Organogenesis Holdings Inc. Reports First Quarter 2022 Financial Results
GlobeNewswire
06:05AM  
Lacklustre Performance Is Driving Organogenesis Holdings Inc.'s (NASDAQ:ORGO) 28% Price Drop
Simply Wall St.
May-05-22 04:05PM  
Organogenesis Appoints Michele Korfin and Gilberto Quintero, Ph.D. to Board of Directors
GlobeNewswire -8.82%
May-02-22 11:08AM  
SPAC Label Is Now a Curse Word That Tars Even Success Stories
Bloomberg
Apr-18-22 01:58PM  
Organogenesis Holdings Inc.'s (NASDAQ:ORGO) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
Simply Wall St.
Apr-05-22 04:30PM  
Organogenesis Showcases Latest Advanced Wound Care Innovations and Research at SAWC Spring 2022 Conference
GlobeNewswire
04:05PM  
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2022 Financial Results on May 10, 2022
GlobeNewswire
Mar-17-22 09:00AM  
Organogenesis Named One of 50 Highest Growth Companies in Massachusetts by the Boston Business Journal
GlobeNewswire
Mar-08-22 07:30AM  
Organogenesis Holdings Inc. to Present at the Oppenheimer Healthcare Conference
GlobeNewswire -5.25%
Mar-04-22 06:46AM  
Do Organogenesis Holdings's (NASDAQ:ORGO) Earnings Warrant Your Attention?
Simply Wall St.
Mar-02-22 05:48PM  
Why Organogenesis Holdings Stock Blasted 21% Higher Today
Motley Fool +21.41%
Mar-01-22 10:00PM  
Organogenesis Holdings Inc. (ORGO) Q4 2021 Earnings Call Transcript
Motley Fool
07:25PM  
Organogenesis (ORGO) Tops Q4 Earnings and Revenue Estimates
Zacks
04:05PM  
Organogenesis Holdings Inc. Reports Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Guidance
GlobeNewswire
Feb-17-22 04:05PM  
Organogenesis Appoints Michael J. Driscoll, Ed.D. to Board of Directors
GlobeNewswire -11.95%
Feb-16-22 08:54AM  
Organogenesis (ORGO) Stock Jumps 7.4%: Will It Continue to Soar?
Zacks
Feb-11-22 07:30AM  
Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in February
GlobeNewswire
Feb-07-22 07:30AM  
Organogenesis Holdings Inc. to Report Fourth Quarter and Fiscal Year 2021 Financial Results on March 1, 2022
GlobeNewswire
Feb-02-22 01:38PM  
Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ...
GuruFocus.com
Feb-01-22 09:38AM  
Wakefield Asset Management LLLP Buys ProShares Short S&P500, Regeneron Pharmaceuticals Inc, ...
GuruFocus.com
Jan-24-22 09:58AM  
Here's Why Organogenesis Holdings (NASDAQ:ORGO) Can Manage Its Debt Responsibly
Simply Wall St.
Jan-20-22 01:00PM  
ORGO Investors Have Opportunity to Lead Organogenesis Holdings Inc. Securities Fraud Lawsuit
PR Newswire
Dec-31-21 07:11PM  
Upcoming Deadline Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
02:49PM  
CLASS ACTION REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. (ORGO) Shareholders of Securities Fraud Class Action Lawsuit
ACCESSWIRE
02:40PM  
UPCOMING DEADLINE ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
PR Newswire
01:00PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-30-21 03:27PM  
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
03:15PM  
ORGO SECURITIES FRAUD: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firms Attorneys, Securities Class Action Filed
ACCESSWIRE
09:45AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-29-21 11:35PM  
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Organogenesis Holdings Inc. of Class Action Lawsuit and Upcoming Deadline - ORGO
PR Newswire
11:27PM  
ALERT: Organogenesis Holdings Inc. Investors with Significant Losses Have Opportunity to Lead Class Action Lawsuit - ORGO
PR Newswire
04:23PM  
Investor Action Notice: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
10:15AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-28-21 05:55PM  
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Shareholders of Securities Fraud Class Action Lawsuit and Encourages Investors with Substantial Losses to Contact the Firm
ACCESSWIRE -5.02%
02:39PM  
Investor Action Alert: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
11:45AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
ACCESSWIRE
09:45AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-27-21 03:22PM  
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
02:20PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
PR Newswire
01:45PM  
Organogenesis Holdings, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
ACCESSWIRE
12:00PM  
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Business Wire
11:00AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-26-21 10:40PM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-25-21 08:10PM  
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc.
PR Newswire
Dec-24-21 03:20PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Organogenesis Holdings (ORGO) Investors to Filing of Securities Fraud Class Action, Encourages Investors with Losses to Contact the Firm
ACCESSWIRE
01:49PM  
Investor Action Notice: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
10:40AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-23-21 09:56PM  
ROSEN, LEADING INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important February 8 Deadline in Securities Class Action - ORGO
PR Newswire
05:10PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
ACCESSWIRE
09:30AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-22-21 05:00PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
ACCESSWIRE
04:36PM  
Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
02:32PM  
DEADLINE ALERT for RVNC, RAAS, ORGO, and XCUR: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
GlobeNewswire
11:00AM  
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Organogenesis Holdings Inc. (ORGO)
Business Wire
09:40AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-21-21 08:07PM  
ORGO ALERT: Robbins Geller Rudman & Dowd LLP Announces that Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Lawsuit
GlobeNewswire +6.54%
07:20PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
PR Newswire
07:18PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
PR Newswire
04:06PM  
Investor Action Notice: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
11:00AM  
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Shareholders of Class Action and Encourages Shareholders to Contact the Firm
ACCESSWIRE
09:20AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
06:02AM  
ORGO Shareholder Alert: Robbins LLP Reminds Investors of Class Action Against Organogenesis Holdings, Inc. (ORGO)
Business Wire
Dec-20-21 08:52PM  
February 8, 2022 Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Organogenesis Holdings Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit
ACCESSWIRE
03:44PM  
Investor Action Alert: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
11:00AM  
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
Business Wire
10:35AM  
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
10:30AM  
Organogenesis Holdings, Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton for More Information
ACCESSWIRE
10:15AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
ACCESSWIRE
10:00AM  
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
Business Wire
09:30AM  
ORGO CLASS ACTION: Hagens Berman, National Trial Attorneys, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firms Attorneys, Securities Fraud Class Action Pending
ACCESSWIRE
Dec-19-21 09:00PM  
ORGANOGENESIS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Organogenesis Holdings, Inc. and Encourages Investors to Contact the Firm
GlobeNewswire
06:34PM  
ORGO NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
ACCESSWIRE
Dec-18-21 12:20PM  
ORGO ALERT: Kessler Topaz Meltzer & Check, LLP Alerts Investors of Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc.
ACCESSWIRE
09:55AM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firms Attorneys Now, Deadline Approaching in Securities Class Action
GlobeNewswire
Dec-17-21 05:11PM  
Kessler Topaz Meltzer & Check, LLP: Reminds Investors of Securities Fraud Class Action Filed Against Organogenesis Holdings Inc.
Business Wire
05:02PM  
Action Reminder: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
04:30PM  
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Organogenesis Holdings Inc. Investors to Secure Counsel Before Important February 8 Deadline in Securities Class Action ORGO
Business Wire
01:00PM  
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
Business Wire
12:30PM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 - ORGO
ACCESSWIRE
11:20AM  
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Organogenesis Holdings Inc. (ORGO) Investors
Business Wire
11:00AM  
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Investors to Contact the Firm
ACCESSWIRE
09:35AM  
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
Dec-16-21 10:53PM  
ORGO Investor Alert: Bronstein, Gewirtz & Grossman, LLC Notifies Organogenesis Holdings Inc. Investors of Class Action and Encourages Shareholders to Contact the Firm
GlobeNewswire
04:15PM  
ORGO SHAREHOLDER ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Organogenesis Holdings Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action ORGO
GlobeNewswire
04:00PM  
ORGO ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of February 8, 2022 in the Class Action Filed on Behalf of Organogenesis Holdings Inc. Shareholders
ACCESSWIRE
03:08PM  
INVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
12:00PM  
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Organogenesis Holdings Inc. (ORGO) on Behalf of Investors
Business Wire
11:00AM  
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Organogenesis Holdings Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
PR Newswire
09:55AM  
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Organogenesis Holdings Inc. a Class Action Lawsuit and a Lead Plaintiff Deadline of February 8, 2022 ORGO
ACCESSWIRE
09:40AM  
ORGO ALERT: Robbins Geller Rudman & Dowd LLP Announces that Organogenesis Holdings Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
ACCESSWIRE
09:30AM  
INVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
ACCESSWIRE
08:50AM  
Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against Organogenesis Holdings Inc. (ORGO)
PR Newswire
Dec-15-21 05:00PM  
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Organogenesis Holdings (ORGO) Investors with Substantial Losses to Contact Firms Attorneys Now, Securities Fraud Class Action Filed
ACCESSWIRE
04:04PM  
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Organogenesis Holdings Inc. with Losses of $100,000 to Contact the Firm
NewMediaWire
03:37PM  
Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Filed Against Organogenesis Holdings Inc. - ORGO
GlobeNewswire
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokines, and ECM proteins in the native tissue are preserved; Apligraf, a bioengineered living cell therapy that produce spectrum of cytokines and growth factors; Dermagraft, a bioengineered product that produces human collagen, ECM, proteins, and cytokines; NuShield, a wound covering tissue includes both amnion and chorion membranes for spongy/intermediate layer intact; PuraPly , a antimicrobial barrier that enables conformability and fluid drainage; and Novachor, an amniotic membrane wound covering in which viable cells, growth factors/cytokines, and ECM proteins are preserved. Its surgical and sports medicine products comprise NuCel, a dehydrated placental tissue surgically applied to the target tissue to support native healing; ReNu, a cryopreserved suspension used to support healing of soft tissues; and FiberOS and OCMP used as a bone void filler primarily in orthopedic and neurosurgical applications. The company's pipeline products include PuraPly XT and PuraPly MZ to treat chronic, acute, and open wounds; PuraForce, a bioengineered porcine collagen surgical matrix for use in soft tissue reinforcement applications; and TransCyte, a bioengineered tissue for the treatment of partial thickness burns. It serves hospitals, wound care centers, government facilities, ambulatory service centers, and physician office through direct sales force and independent agencies. The company was founded in 1985 and is headquartered in Canton, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ERANI ALBERT10% OwnerJun 13Sale4.8929,669145,08159,248,027Jun 13 05:43 PM
ERANI ALBERT10% OwnerJun 13Sale4.8929,669145,08159,248,027Jun 13 05:44 PM
ERANI ALBERT10% OwnerJun 09Sale5.303311,75459,277,696Jun 13 05:44 PM
ERANI ALBERT10% OwnerJun 09Sale5.303311,75459,277,696Jun 13 05:43 PM
ERANI ALBERT10% OwnerJun 08Sale5.3920,000107,80059,278,027Jun 08 07:11 PM
ERANI ALBERT10% OwnerJun 08Sale5.3920,000107,80059,278,027Jun 08 07:13 PM
ERANI ALBERT10% OwnerJun 07Sale5.4950,000274,50059,298,027Jun 08 07:13 PM
ERANI ALBERT10% OwnerJun 07Sale5.4950,000274,50059,298,027Jun 08 07:11 PM
ERANI ALBERT10% OwnerJun 06Sale5.41100,000541,00059,348,027Jun 08 07:11 PM
ERANI ALBERT10% OwnerJun 06Sale5.41100,000541,00059,348,027Jun 08 07:13 PM
Gillheeney Gary S.President and CEOJun 03Option Exercise0.9936,23935,877434,481Jun 03 04:51 PM
Gillheeney Gary S.President and CEOJun 03Sale5.5336,239200,402398,242Jun 03 04:51 PM
Gillheeney Gary S.President and CEOJun 02Option Exercise0.99116,608115,442514,850Jun 03 04:51 PM
Gillheeney Gary S.President and CEOJun 02Sale5.58116,608650,673398,242Jun 03 04:51 PM
Gillheeney Gary S.President and CEOJun 01Option Exercise0.9994,48793,542492,729Jun 03 04:51 PM
Gillheeney Gary S.President and CEOJun 01Sale5.5294,487521,568398,242Jun 03 04:51 PM
Gillheeney Gary S.President and CEOMay 31Option Exercise0.99109,240108,148507,482May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 31Sale5.68109,240620,483398,242May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 27Option Exercise0.9956,36255,798454,604May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 27Sale5.9356,362334,227398,242May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 26Option Exercise0.9961,20260,590459,444May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 26Sale5.7161,202349,463398,242May 31 05:16 PM
Gillheeney Gary S.President and CEOMay 25Option Exercise0.9984,67483,827482,916May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 25Sale5.6084,674474,174398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 24Option Exercise0.9952,31251,789450,554May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 24Sale5.6652,312296,086398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 23Option Exercise0.9960,35059,746458,592May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 23Sale5.8060,350350,297398,242May 25 06:18 PM
Gillheeney Gary S.President and CEOMay 20Option Exercise0.9958,65458,067456,896May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 20Sale5.8958,654345,472398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 19Option Exercise0.99118,504117,319516,746May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 19Sale5.94118,504703,914398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 18Option Exercise0.9986,53185,666484,773May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 18Sale5.4686,531472,459398,242May 20 06:13 PM
Gillheeney Gary S.President and CEOMay 17Option Exercise0.9998,07897,097496,320May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 17Sale5.9098,078578,660398,242May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 16Option Exercise0.9980,36979,565478,611May 17 08:11 PM
KATZ MICHAEL W10% OwnerMay 16Buy6.0310,00060,29870,382May 18 05:04 PM
Gillheeney Gary S.President and CEOMay 16Sale5.9280,369475,784398,242May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 13Option Exercise0.99136,390135,026534,632May 17 08:11 PM
Gillheeney Gary S.President and CEOMay 13Sale6.17136,390841,113398,242May 17 08:11 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 10Option Exercise3.4668,504237,024141,725Mar 11 06:42 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 10Sale8.3997,436817,48844,289Mar 11 06:42 PM
Montecalvo Antonio S.Vice President, Health PolicyMar 09Sale8.5210,00085,20073,221Mar 11 06:42 PM
KATZ MICHAEL W10% OwnerDec 13Buy9.655004,82560,382Dec 14 06:47 PM
KATZ MICHAEL W10% OwnerDec 03Buy9.358007,48059,882Dec 06 05:48 PM
KATZ MICHAEL W10% OwnerDec 02Buy9.661,80017,39059,082Dec 06 05:48 PM
KATZ MICHAEL W10% OwnerNov 29Buy9.751,0009,75057,282Dec 01 06:17 PM
KATZ MICHAEL W10% OwnerNov 26Buy9.792,00019,57056,282Nov 30 08:15 PM
GN 2016 Organo 10-Year GRAT u/10% OwnerNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
NUSSDORF GLENN HDirectorNov 18Buy9.9325,000248,25059,448,027Nov 22 08:39 PM
KATZ MICHAEL W10% OwnerNov 17Buy10.871,00010,87054,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 15Buy11.081,00011,08053,282Nov 19 05:03 PM
KATZ MICHAEL W10% OwnerNov 12Buy11.203,00033,60052,282Nov 19 05:03 PM
Bilbo PatrickChief Operating OfficerNov 10Option Exercise1.4430,45043,848133,670Nov 12 06:01 PM
KATZ MICHAEL W10% OwnerAug 17Buy13.5512,000162,60049,282Aug 19 07:38 PM
Gillheeney Gary S.President and CEOJul 19Option Exercise0.99160,237158,635292,154Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 19Sale14.02160,2372,246,523131,917Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Option Exercise3.51139,763490,488271,680Jul 20 08:45 PM
Gillheeney Gary S.President and CEOJul 16Sale14.74139,7632,059,820131,917Jul 20 08:45 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do Not Sell My Data • Privacy Settings
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2022 FINVIZ.com. All Rights Reserved.